Skip to content

Clinical Validation of NAVOY® Acute Kidney Injury in Swedish ICU Patients

Clinical Validation of NAVOY® Acute Kidney Injury in Swedish ICU Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05424874
Acronym
ExTRACT
Enrollment
304
Registered
2022-06-21
Start date
2020-12-02
Completion date
2021-11-01
Last updated
2022-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Brief summary

The study aims to evaluate the performance of the prediction algorithm NAVOY® AKI in a Swedish adult ICU patient population versus fulfilment of KDIGO diagnostic criteria.

Interventions

None listed

Sponsors

AlgoDx
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* The study will only include the subjects from the SEP-SE-02 study population. (NCT04570618)

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Prediction performance of NAVOY® AKIData from ICU stay between December 2020 to October 2021.The sensitivity, specificity, and accuracy will be calculated comparing the algorithm's predictions with the true AKI outcome.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026